Latest Eisai Stories
-- Expansion to Approximately 600 Sales Specialists Follows Initiation of National Television Advertising Campaign -- SAN DIEGO, May 9, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Expansion Enables Eisai to Reach 90,000 Healthcare Providers WOODCLIFF LAKE, N.J., May 9, 2014 /PRNewswire/ -- Eisai Inc.
-- Doctors Can Help Patients Set Personal Weight Loss Goals: It's Not a One Size Fits All Approach -- WOODCLIFF LAKE, N.J., April 29, 2014 /PRNewswire/ -- Eisai Inc.
Patent covers methods of use for small molecule inhibitors in the treatment of NHL, including follicular and diffuse large B-cell lymphomas CAMBRIDGE, Mass., April 24, 2014 /PRNewswire-USNewswire/
Campaign Creates Awareness of Prescription Drug Option for Chronic Weight Management WOODCLIFF LAKE, N.J., April 14, 2014 /PRNewswire/ -- Eisai Inc.
Patent provides protection until 2033 and complements Epizyme's issued composition of matter claims for EZH2 inhibitors CAMBRIDGE, Mass., April 8, 2014 /PRNewswire/ -- Epizyme, Inc.
WOODCLIFF LAKE, N.J., March 31, 2014 /PRNewswire/ -- Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license
Sisters Network® Inc.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, March 12, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
LONDON, March 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- To give a box on the ear to.